Brokerages Set Zoetis Inc. (NYSE:ZTS) Price Target at $224.88

Zoetis Inc. (NYSE:ZTS) has been given an average rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $221.75.

Several research firms have commented on ZTS. Jefferies Financial Group reiterated a “buy” rating and issued a $230.00 target price on shares of Zoetis in a research report on Tuesday, December 19th. Piper Sandler reiterated an “overweight” rating and issued a $195.00 target price (down from $220.00) on shares of Zoetis in a research report on Tuesday. The Goldman Sachs Group increased their price target on Zoetis from $190.00 to $226.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. StockNews.com cut Zoetis from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Finally, Stifel Nicolaus decreased their price target on Zoetis from $215.00 to $195.00 and set a “buy” rating for the company in a research note on Tuesday, April 2nd.

Insider Buying and Selling

In other Zoetis news, EVP Roxanne Lagano sold 923 shares of the stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $173.33, for a total value of $159,983.59. Following the transaction, the executive vice president now owns 15,723 shares in the company, valued at $2,725,267.59. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders sold 2,209 shares of company stock valued at $408,453 over the last 90 days. Company insiders own 0.12% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Hohimer Wealth Management LLC lifted its holdings in Zoetis by 1.2% during the fourth quarter. Hohimer Wealth Management LLC now owns 4,386 shares of the company’s stock worth $866,000 after acquiring an additional 52 shares during the period. Enterprise Financial Services Corp grew its position in shares of Zoetis by 2.3% in the first quarter. Enterprise Financial Services Corp now owns 2,446 shares of the company’s stock valued at $407,000 after purchasing an additional 55 shares in the last quarter. Forum Financial Management LP grew its position in Zoetis by 0.8% during the fourth quarter. Forum Financial Management LP now owns 7,386 shares of the company’s stock worth $1,458,000 after buying an additional 56 shares in the last quarter. Angeles Wealth Management LLC grew its position in Zoetis by 3.5% during the fourth quarter. Angeles Wealth Management LLC now owns 1,640 shares of the company’s stock worth $324,000 after buying an additional 56 shares in the last quarter. Finally, Prossimo Advisors LLC grew its position in Zoetis by 1.7% during the fourth quarter. Prossimo Advisors LLC now owns 3,498 shares of the company’s stock worth $690,000 after buying an additional 57 shares in the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Price Performance

Shares of ZTS stock opened at $153.02 on Friday. The company has a quick ratio of 2.00, a current ratio of 3.36 and a debt-to-equity ratio of 1.32. Zoetis has a twelve month low of $148.48 and a twelve month high of $201.92. The company has a market cap of $69.99 billion, a P/E ratio of 30.18, a P/E/G ratio of 2.29 and a beta of 0.85. The business has a fifty day simple moving average of $178.25 and a 200 day simple moving average of $180.59.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, February 13th. The company reported $1.24 EPS for the quarter, missing the consensus estimate of $1.32 by ($0.08). The firm had revenue of $2.21 billion during the quarter, compared to the consensus estimate of $2.19 billion. Zoetis had a net margin of 27.43% and a return on equity of 51.25%. Zoetis’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.15 earnings per share. On average, sell-side analysts forecast that Zoetis will post 5.8 EPS for the current fiscal year.

Zoetis Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 4th. Investors of record on Friday, April 19th will be paid a dividend of $0.432 per share. The ex-dividend date is Thursday, April 18th. This represents a $1.73 annualized dividend and a yield of 1.13%. Zoetis’s dividend payout ratio is currently 33.93%.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.